SCHEMBL5264074

SCHEMBL5264074

COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cccnc3[nH]2)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.78
DRD3 P35462 10/20 0.78
DRD4 P21917 9/20 0.78
HTR1A P08908 3/20 0.65
ADRA2A P08913 3/20 0.65
DRD1 P21728 2/20 0.65
ADRA1D P25100 2/20 0.65
HTR2A P28223 2/20 0.65
HTR2C P28335 2/20 0.65
ADRA1A P35348 2/20 0.65
ADRA1B P35368 2/20 0.65
HTR2B P41595 2/20 0.65
MEN1 O00255 1/20 0.65
LMNA P02545 1/20 0.65
TP53 P04637 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2D6 P10635 1/20 0.65
TSHR P16473 1/20 0.65
NFKB1 P19838 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5504452 0.88 DRD3 (1.00) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL6357580 0.85 DRD3 (0.94) DRD2DRD3DRD4HTR1AADRA2A
SCHEMBL5264300 0.84 DRD2 (0.66) DRD2DRD3DRD4HTR1AADRA1D
SCHEMBL14339848 0.83 DRD3 (0.76) DRD2DRD3DRD4HTR1ADRD1
Hydrochloric Acid SCHEMBL9134513 0.83 DRD3 (0.91) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL9653912 0.81 DRD2 (0.74) DRD2DRD3DRD4HTR1AADRA1D
SCHEMBL9650872 0.80 DRD2 (0.80) DRD2DRD3DRD4HTR1AADRA1D
SCHEMBL5266646 0.80 DRD3 (0.55) DRD2DRD3DRD4HTR1AHTR2A
Bp-897 SCHEMBL26086545 0.79 DRD2 (0.96) DRD2DRD3DRD4HTR1AADRA2A
Bp-897 SCHEMBL30027453 0.79 DRD2 (1.00) DRD2DRD3DRD4HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299091-A1 Azaindole Carboxamides GMEINER PETER 2007-12-27 US disclosed
US-20070299091-A1 Azaindole Carboxamides GMEINER PETER 2007-12-27 US disclosed
EP-1771448-A1 AZAINDOLE CARBOXAMIDES SCHWARZ PHARMA AG (DE) 2007-04-11 EP disclosed
WO-2006050976-A1 AZAINDOLE CARBOXAMIDES SCHWARZ PHARMA AG (DE) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299091-A1 Azaindole Carboxamides TPH1, TPH2, HTR1A DRD2 64/4885DRD3 176/4885DRD4 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.